Program
testosterone 17 beta-cypionate
Also written as “Testosterone Cypionate 75 mg”, “Testosterone cypionate 50 mg” and “Testosterone cypionate 100 mg”.
Its studies are mostly in Eunuchism, led by 2 companies.
Drug pageTestosterone 17 beta-cypionate: every studyAll 27 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Amneal Pharmaceuticalsits history only | 11 open or running | phase 3since Oct 21, 2026 | Oct 21, 2026 | Mar 31, 2027phase 3 · NCT07898072 |
| Azurity Pharmaceuticalsits history only | 11 open or running | phase 4since Jan 7, 2026 | Jan 7, 2026 | Jun 2027phase 4 · NCT07328542 |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 7, 2026First study: phase 4 study in EunuchismNew to Azurity PharmaceuticalsAzurity Pharmaceuticals · NCT07328542 · 144 planned · United States
- Oct 21, 2026Amneal Pharmaceuticals’ first study: phase 3 study in EunuchismNew to Amneal PharmaceuticalsAmneal Pharmaceuticals · NCT07898072 · 190 planned · United States
Ahead
- Mar 31, 2027Primary completion: phase 3 study in EunuchismAmneal Pharmaceuticals · NCT07898072
- Jun 2027Primary completion: phase 4 study in EunuchismAzurity Pharmaceuticals · NCT07328542
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07898072Eunuchism · United States | 3 | Recruiting | Amneal Pharmaceuticals | Mar 31, 2027 | 190 |
| NCT07328542Eunuchism · United States | 4 | Not yet recruiting | Azurity Pharmaceuticals | Jun 2027 | 144 |
How it is read
Names in the registry
- “Testosterone Cypionate 75 mg”, 1 entry
- “Testosterone cypionate 50 mg”, 1 entry
- “Testosterone cypionate 100 mg”, 1 entry
- “Testosterone Cypionate Injection 200 mg/mL”, 1 entry
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.